UCLA researchers this week published data that for the first time shows human blood stem cells can be engineered to attack HIV-infected cells and that the process could not only prove to be a breakthrough for AIDS patients but also for the sufferers of other viral diseases.
The UCLA AIDS Institute study was published this week in the online journal Plos ONE. The research proves the feasibility "that human stem cells can be engineered into the equivalent of a genetic vaccine," according to an institute statement.
http://blogs.laweekly.com/ladaily/city-news/huge-aids-breakthrough-from-uc/
An HIV genetic stowaway that may have come from a related cat virus could help the AIDS virus transmit and replicate in people, U.S. researchers reported on Sunday.
Their finding, which has implications for designing new drugs or a vaccine against the fatal and incurable virus, may also shed light on how other viruses, such as swine flu, spread from animals to people, experts said.
http://abcnews.go.com/Health/wireStory?id=9264450
The combination of two vaccines that has previously failed to produce a response on their own has cut the risk of becoming infected with HIV by more than 31 per cent.
It is the first time in human trials that a vaccine has protected against the virus which leads to Aids.